American Century Companies’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
JT
PA
NAMI
American Century Companies's TVTX Position: Q2 2026 in Review
American Century Companies increased its Travere Therapeutics (TVTX) stake by 8.8% in Q2 2026, buying an estimated $92.4K and bringing the position to 25,899 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2299.
American Century Companies first reported a position in TVTX in Q3 2016 and has held it in 10 quarters since. The position peaked at $7.12M in Q3 2017. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- American Century Companies held 25,899 shares of Travere Therapeutics worth $1.47M as of Q2 2026.
- American Century Companies bought 2,085 Travere Therapeutics shares in Q2 2026, an estimated $92.4K.
- Travere Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2299 holding.
- American Century Companies first reported a position in Travere Therapeutics in Q3 2016 and has held it in 10 quarters since.
- American Century Companies's Travere Therapeutics position peaked at $7.12M in Q3 2017.
- 320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.